Medical devices, healthcare technology and the business of care
PMA approval · P980040

SENSAR SOFT ACRYLIC UV-LIGHT ABSORBING POSTERIOR CHAMBER INTRAOCULAR LENS

Johnson & Johnson Surgical Vision, Inc. · Decision date Feb 3, 2000

MEDTECHLEDGER EXPLANATIONP980040

What did the FDA approve?

The FDA database entry for P980040 records an approval dated February 3, 2000, for the AMO SENSAR Soft Acrylic, UV Light-Absorbing, Posterior Chamber Intraocular Lens, Model AR40. The stated indication is visual correction of aphakia in persons 60 years of age or older after removal of a cataractous lens by extracapsular cataract extraction, with placement intended in the capsular bag.

The entry identifies the applicant as Johnson & Johnson Surgical Vision, Inc., the product code as HQL, and the specialty as Ophthalmic. No supplement type or supplement reason is listed, so the record does not describe a change to a prior approval. The decision field contains only the approval statement; the entry does not include clinical data, trial results, or independent safety or effectiveness findings.

FDA approval order statement

Approval for the AMO SENSAR Soft Acrylic, UV Light-Absorbing, Posterior Chamber Intraocular Lens (IOL), Model AR40. This device is indicated for the visual correction of aphakia in persons 60 years of age or older in whom a cataractous lens has been removed by extracapsular cataract extraction. The lens is intended to be placed in the capsular bag.
Regulatory pathway
Original PMA
Clinical specialty
Ophthalmic
Decision date
Feb 3, 2000

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P980040
Regulatory pathway
Premarket approval application
Product code
HQL
Decision code
APPR
Decision date
Feb 3, 2000
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: intraocular lens.

Product code
HQL
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P980040 received

    Application receipt date recorded by FDA.

  2. P980040 · FDA decision

    APPR

  3. P980040/S186 · Related supplement

    SENSAR 3-Piece Monofocal IOL, SENSAR 1-piece IOL, TECNIS Multi-focal 1-pc, TECNIS 1-PC OptiBlue IOL, TECNIS OptiBlue 1-P

Timeline entries are records held by MedtechLedger for P980040. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P980040

Explore the linked device profile

Other records with product code HQL

Product / regulatory recordCompanyPathwayDecision dateSource
Beaver-Visitec International, Inc.PMA supplementOct 27, 2026FDA
Carl Zeiss Meditec Production, LLCPMA supplementOct 23, 2026FDA
Bausch + Lomb, Inc.PMA supplementOct 23, 2026FDA
Johnson & Johnson Surgical Vision, Inc.PMA supplementOct 19, 2026FDA
Bausch + Lomb, Inc.PMA supplementOct 14, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Johnson & Johnson Surgical Vision, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
31 Technology Dr., Suite 200, Irvine, CA, 92618

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records